Introduction
Qatar's healthcare industry is expanding quickly, leading to the demand for specialty medicines such as Prolia (Denosumab 60 mg injection) and Oxitan (Oxaliplatin injection). Qatar benefits from the fact that M Care, a trusted pharmaceutical exporter from India and manufacturer of these drugs, supplies them with a consistent authentic and licensed supply in the country. We supply our clients with healthcare facilities, medical centers, and pharmaceutical pharmacies, guaranteeing prompt delivery and complete compliance with Qatari import laws.
Prolia (Denosumab Injection) in Qatar
Denosumab injection, also known as Prolia in Qatar, is commonly prescribed to treat osteoporosis and cancer-associated bone loss.
Uses & Indications
- In women who are post-menopausal, denosumab is prescribed to treat osteoporotic conditions.
- Denosumab for cancer-related bone loss.
- Hypercalcemia management in cancer patients is managed by denosumab.
Mechanism of Action
- By blocking RANK ligand (RANKKL), denosumab prevents the formation of osteoclast, which reduces bone resorption and increases bone density.
Dosage & Administration
- Prolia 60 mg every 6 months. Injections.
- Provided with medical attention in Qatari hospitals and clinics.
- In certain cases, the use of inj Denosumab 120 mg may be necessary based on clinical recommendations.
Side Effects & Precautions
- Common: Joint pain, backache and skin infections are common.
- Indicative: Hypocalcemia and osteonecrosis of the jaw.
- Contraindications: Low calcium, infections, pregnancy.
Oxitan (Oxaliplatin Injection) – Exported to Qatar from India
A platinum-based chemotherapy drug called Oxitan is commonly used in Qatar to treat colorectal and gastrointestinal cancers.
Uses & Indications
- Colorectal cancer and GI tumors.
- Commonly administered alongside capecitabine or irinotecan as part of their combination therapy.
Mechanism of Action
- Oxaliplatin is used in chemotherapy as it binds to DNA, inhibiting replication and leading to the death of cancer cells.
Dosage & Administration
- Administered intravenously in cycles according to treatment protocols.
- Available in Qatar in vials of 50 mg and 100 mg.
Side Effects
- Neuropathy causes tingling/numbness in hands and feet. Hair loss, nausea, vomiting, fatigue.
- Allergic reactions or long-term neuropathy.
Price & Availability – Qatar
- Competitive rates for denosumab injection in Qatar.
- Qatar sells oxaliplatin injection in vials of 50 mg and 100 mg, which have a higher cost.
- MCare is the preferred supplier for exporting wholesale supply from India to Qatar, specifically to hospitals and pharmacies.
Why Choose MCare as Your Exporter to Qatar?
- Direct supply from licensed Indian manufacturers.
- WHO-GMP certified products.
- Cold-chain observance to maintain the effectiveness of medicines.
- Regulatory support to facilitate smooth imports into Qatar.
- Acquired by hospitals, clinics and pharmacies throughout Qatar.
Product Categorisation – For Clients in Qatar
- In cases of bone health concerns, osteoporosis and dental problems are linked to the use of prostaglan jelly.
- Oncology: Oxitan / Oxaliplatin.
- Extra Services: Immune, Pain, Hepatitis, Critical Care.
The Qatar Market Advantage
- High reliance on imported specialty drugs.
- The Government has invested heavily in advanced healthcare infrastructure.
- Growing knowledge of osteoporosis and cancer therapies.
- Opportunities to establish long-term relationships with hospitals and pharmacy.
Conclusion
Prolia (Denosumab injection) and Oxitan (Oxaliplatin injection), both in high demand in the Qatar market. M Care is your go-to exporting partner from India, providing genuine, top-notch medicines to healthcare providers in Qatar that comply with regulations, cold-chain logistics, and have dependable delivery.
